Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
Anondita Medicare Limited clarified procedures for handling odd lots of Rights Entitlements and shares during its ongoing Rights Issue. No new transaction value is involved.
Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.
Anondita Medicare Ltd reported revenue from operations of ₹54.1 Cr (+72.3% YoY) and net profit of ₹13 Cr (+116.7% YoY) for H1 FY26.
Anondita Medicare Limited (ANONDITA) reports FY26 revenue of ₹13,741.57 Cr with 37.5% EBITDA margins. The company is scaling capacity and expanding internationally across Brazil and South Africa.
Anondita Medicare reported strong FY26 results with revenue growing 78% YoY to ₹137.42cr and PAT rising 107% to ₹34.30cr. Strategy focuses on high-margin female condoms and international market expansion.
Anondita Medicare Ltd reported revenue from operations of ₹83.3 Cr and net profit of ₹21.3 Cr for H2 FY26.
Anondita Medicare (formerly Anondita Healthcare) reported strong FY26 performance, achieving ₹137.4cr revenue and ₹34.3cr PAT. Strategy focuses on expanding high-margin female condom production and global exports.
Anondita Medicare Ltd reported revenue from operations of ₹83.3 Cr (+82.7% YoY) and net profit of ₹21.3 Cr (+102.9% YoY) for H2 FY26.